Rituximab is a safe and effective long-term treatment for children with steroid and calcineurin inhibitor-dependent idiopathic nephrotic syndrome
Pietro Ravani, Alessandro Ponticelli, Chiara Siciliano, Alessia Fornoni, Alberto Magnasco, Felice Sica, Monica Bodria, Gianluca Caridi, Changli Wei, Mirco Belingheri, Luciana Ghio, Sandra Merscher-Gomez, Alberto Edefonti, Andrea Pasini, Giovanni Montini, Corrado Murtas, Xiangyu Wang, Daniel Muruve, Augusto Vaglio, Davide MartoranaAntonello Pani, Francesco Scolari, Jochen Reiser, Gian M. Ghiggeri
Research output: Contribution to journal › Article › peer-review
Dive into the research topics of 'Rituximab is a safe and effective long-term treatment for children with steroid and calcineurin inhibitor-dependent idiopathic nephrotic syndrome'. Together they form a unique fingerprint.